Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Although genetic factors contribute to almost half of all cases of deafness, treatment options for genetic deafness are limited. We developed a genome-editing approach to target a dominantly inherited form of genetic deafness. Here we show that cationic lipid-mediated in vivo delivery of Cas9-guide RNA complexes can ameliorate hearing loss in a mouse model of human genetic deafness. We designed and validated, both in vitro and in primary fibroblasts, genome editing agents that preferentially disrupt the dominant deafness-associated allele in the Tmc1 (transmembrane channel-like gene family 1) Beethoven (Bth) mouse model, even though the mutant Tmc1 Bth allele differs from the wild-type allele at only a single base pair. Injection of Cas9-guide RNA-lipid complexes targeting the Tmc1 Bth allele into the cochlea of neonatal Tmc1 Bth/+ mice substantially reduced progressive hearing loss. We observed higher hair cell survival rates and lower auditory brainstem response thresholds in injected ears than in uninjected ears or ears injected with control complexes that targeted an unrelated gene. Enhanced acoustic startle responses were observed among injected compared to uninjected Tmc1 Bth/+ mice. These findings suggest that protein-RNA complex delivery of target gene-disrupting agents in vivo is a potential strategy for the treatment of some types of autosomal-dominant hearing loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, lipid-mediated nanoparticle (LNP) delivery has been used to transport CRISPR-Cas components in the form of either mRNA/sgRNA or preassembled RNPs into tissues 71-74 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [74]
In the citing paper
“Additionally, lower auditory response thresholds and improved acoustic responses were observed in injected mice.[226]”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [226]
In the citing paper
“The intraaural injection of Cas9 RNPs/lipofectamine 2000 complexes into the scala media of neonatal Tmc1Bth/+ mice significantly increased the survival of hair cells.”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [226]
In the citing paper
“All these results demonstrated that this system substantially reduced progressive hearing loss in Beethoven mouse model (Fig. 3B) [113].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268 · cited 4×
“We identified three candidate sgRNAs (Tmc1-mut1, Tmc1-mut2, and Tmc1-mut3) that place the Bth mutation at position 11, 12, or 15, respectively, of the spacer, counting the PAM as positions 21-23 (Fig.”
InfluentialImproving CRISPR-Cas nuclease specificity using truncated guide RNAs
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993 · cited 1×
“A fourth sgRNA, Tmc1-mut4, is a truncated version of Tmc1-mut3 designed to increase genome editing DNA specificity 22 .”
Kim, S., Kim, D., Cho, S. W., Kim, J., & Kim, J.-S. (2014) · Genome Research · doi:10.1101/gr.171322.113 · Cited by 1,856
Newborn Hearing Screening — A Silent Revolution
Morton, C. C., & Nance, W. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050700 · Cited by 1,686
Pattanayak, V., Lin, S., Guilinger, J. P., Ma, E., Doudna, J. A., & Liu, D. R. (2013) · Nature Biotechnology · doi:10.1038/nbt.2673 · Cited by 1,487
Self-citationZuris, J. A., Thompson, D. B., Shu, Y., Guilinger, J. P., Bessen, J. L., Hu, J. H., Maeder, M. L., Joung, J. K., Chen, Z.-Y., & Liu, D. R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3081 · Cited by 1,460
Self-citationCRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
Komor, A. C., Badran, A. H., & Liu, D. R. (2017) · Cell · doi:10.1016/j.cell.2016.10.044 · Cited by 1,013
Self-citationLong, C., Amoasii, L., Mireault, A. A., McAnally, J. R., Li, H., Sanchez-Ortiz, E., Bhattacharyya, S., Shelton, J. M., Bassel-Duby, R., & Olson, E. N. (2016) · Science · doi:10.1126/science.aad5725 · Cited by 937
Yin, H., Song, C.-Q., Dorkin, J. R., Zhu, L. J., Li, Y., Wu, Q., Park, A., Yang, J., Suresh, S., Bizhanova, A., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3471 · Cited by 876
Self-citationEfficient delivery of genome-editing proteins using bioreducible lipid nanoparticles
Wang, M., Zuris, J. A., Meng, F., Rees, H., Sun, S., Deng, P., Han, Y., Gao, X., Pouli, D., Wu, Q., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520244113 · Cited by 624
Self-citation
Cited by
Items 501–566 of 566
Cho, S. H., Yun, Y., Lee, D. H., Cha, J. H., Lee, S. M., Lee, J., Suh, M. H., Lee, J. H., Oh, S.-H., Park, M. K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26651283
Cho, S. H., Yun, Y., Lee, D. H., Cha, J. H., Lee, S. M., Lee, J., Suh, M. H., Lee, J. H., Oh, S.-H., Park, M. K., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24779237
Cho, S. H., Yun, Y., Lee, D. H., Cha, J. H., Lee, S. M., Lee, J., Suh, M. H., Lee, J. H., Oh, S.-H., Park, M. K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26651286
Bases moleculares de la sordera: envejecimiento y nuevas fronteras en la investigación auditiva
Cervantes, B., Larrubia, P. L., Varela‐Nieto, I., & Murillo‐Cuesta, S. (2025) · Auditio · doi:10.51445/sja.auditio.vol9.2025.123
Integrating Regenerative Medicine and Stem Cell Therapy in Hearing Restoration: A Systematic Review
Hussain, I. D., Tanveer, H., Hussain, M. A., Rashid, H., Eldin, O. S., & Khalil, H. (2026) · Cureus · doi:10.7759/cureus.117530
Investigating the functional roles of microRNA-29b and microRNA-146a in prion diseases
Zhao, W. (2018) · Minerva Access (University of Melbourne)
Yamoah, E. N. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735335253.793584992
Utilizing CRISPR/Cas9 Technologies for in vivo Disease Modeling and Therapy
Badertscher, L., & Porritt, M. J. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch7
Recent advances in cellular and gene therapies for cancer
Rui, M. I. A. O., Xing, S.-P., ZHEGN, S.-G., & Lian-Hui, S. U. N. (2026) · Shengming kexue · doi:10.3724/cbls.2026071
Burgio, G. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.29002.gbu
Stem cells, bioengineering, and 3D scaffolds for neural tissue engineering
Ikram, F., Ilhan, E., Yıldırım, R., & Ekren, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90554-1.00005-7
Gu, X. G., Wang, D., Xu, Z., Wang, J., Guo, L., Chai, R., Li, G., Shu, Y., & Li, H. (2021) · Figshare · doi:10.6084/m9.figshare.14266959
Self-citationGu, X. G., Wang, D., Xu, Z., Wang, J., Guo, L., Chai, R., Li, G., Shu, Y., & Li, H. (2021) · Figshare · doi:10.6084/m9.figshare.14266965
Self-citationGu, X. G., Wang, D., Xu, Z., Wang, J., Guo, L., Chai, R., Li, G., Shu, Y., & Li, H. (2021) · Figshare · doi:10.6084/m9.figshare.14266956
Self-citationXi, G., Wang, D., Xu, Z., Wang, J., Guo, L., Chai, R., Li, G., Shu, Y., & Li, H. (2021) · Figshare · doi:10.6084/m9.figshare.14266968
Self-citationGu, X. G., Wang, D., Xu, Z., Wang, J., Guo, L., Chai, R., Li, G., Shu, Y., & Li, H. (2021) · Figshare · doi:10.6084/m9.figshare.14266971
Self-citationGu, X., Wang, D., Xu, Z., Wang, J., Guo, L., Chai, R., Li, G., Shu, Y., & Li, H. (2021) · Figshare · doi:10.6084/m9.figshare.14266953
Self-citationGu, X., Wang, D., Xu, Z., Wang, J., Guo, L., Chai, R., Li, G., Shu, Y., & Li, H. (2021) · Figshare · doi:10.6084/m9.figshare.14266974
Self-citationGu, X., Wang, D., Xu, Z., Wang, J., Guo, L., Chai, R., Li, G., Shu, Y., & Li, H. (2021) · Figshare · doi:10.6084/m9.figshare.14266962
Self-citationEmerging Therapies for Genetic Deafness: The Rise of Precision Gene Editing
Lahlou, G., Cornille, M., Lai, N., Lecomte, M.-J., & Safieddine, S. (2026) · Ear and Hearing · doi:10.1097/aud.0000000000001903
Chitin – A Natural Bio‐feedstock and Its Derivatives
Singh, A. T., Jaiswal, S., Kumar, S., & Dutta, P. K. (2022) · Wiley eBooks · doi:10.1002/9781119655749.ch9
Yip, K. Y.-L. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733997652.793551737
Mechanotransduction and Inner Ear Function
Xiong, W. (2018) · SpringerBriefs in biochemistry and molecular biology · doi:10.1007/978-981-10-8557-4_5
Gene Therapy Approaches for Cochlear Repair
Richardson, R. T., & Gunewardene, N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.24135-7
竹田, 大., & 折田, 頼. (2022) · Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo) · doi:10.3950/jibiinkotokeibu.125.6_953
Weber, P. C. (2026) · Springer eBooks · doi:10.1007/978-3-032-25356-9_27
Gene Therapy for Congenital Hearing Loss
Timashpolsky, A., Chorney, S. R., & O’Reilly, R. (2022) · Current Otorhinolaryngology Reports · doi:10.1007/s40136-022-00427-0
Engert, J., Doll, J., Vona, B., Kasemo, T. E., Spahn, B., Hagen, R., Rak, K., & Voelker, J. (2023) · Life · doi:10.3390/life13091858
Transient CRISPR-Cas delivery for therapeutic gene editing in the retina
Botto, C. (2022) · theses.fr (ABES) · doi:10.70675/b0c6037fz0240z4844z9036z7867f920dadc
A review on: CRISPR-based gene therapy in pharmacy: A revolutionary approach in modern therapeutics
Shimpi, V. D., Padwal, P. N., & Rode, S. S. (2026) · World Journal of Biology Pharmacy and Health Sciences · doi:10.30574/wjbphs.2026.26.1.0230
Avances en la terapia génica para enfermedades hereditarias en oftalmología y otorrinolaringología
Vela, M. J. O., Maldonado, A. P. C., Noboa, C. E. N., Maldonado, J. J. A., Noboa, A. R. N., Sandoval, G. A. R., Rueda, M. P. M., & Ávalos, Y. B. B. (2026) · Ibero-American Journal of Health Science Research · doi:10.56183/iberojhr.v6i1.889
Vertebrate opsin-based optogenetics for highly sensitive vision restoration
Rucli, M. (2024) · theses.fr (ABES) · doi:10.70675/3d316836ze86bz4f4ezbd75z8217449fe0e7
Expanding the Capabilities of Genome Editing
Rees, H. A. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Happel, L. (2024) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.59437
CRISPR-CAS9 Applications In Gene Editing For Rare Genetic Disorders
Gam, M. A. (2025) · South Eastern European Journal of Public Health
RESTORING AUDITORY FUNCTION IN MAMMALS USING AAV-BASED GENE THERAPY
Amariutei, A.-E. (2023) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Qiao, J., Sun, W., Yin, W., Hu, L., Wang, X., & Liu, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143121
AAV8-mediated CasRx delivery and expression in the cochlea and cochlear nucleus of mice
Zhou, S., Huang, T., Yao, W., HUANG, S. H., Jiang, J., Liao, H., & Xia, Z. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102829
Development of targeted methylome modifications in mammal cells
Lleida, A. A. (2018) · theses.fr (ABES)
Ibraheim, R. (2020) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/ey4j-tj18
Peng, H. (2019) · UTS ePRESS (University of Technology Sydney)
Genome variation over multiple timescales and dimensions
Keough, K. C. (2020) · eScholarship (California Digital Library)
CRISPR/Cas gene editing based therapy approach in clinical therapeutics
Srikanth, M., Manikanta, S. U., Shaik, S. B., Mollety, B., & Geetha, R. V. (2025) · Research Journal of Biotechnology · doi:10.25303/208rjbt2560263
Samarajeewa, A. (2018) · TSpace (University of Toronto)
マウスの内耳にアデノ随伴ウイルスを介した遺伝子の局所注入後に生じる自然免疫反応と獲得免疫反応について
Yasuko, I., ヤスコ, イ., & Yasuko, I. (2025) · Terrestrial Environment Research Center (University of Tsukuba) · doi:10.15068/0002021262
de Almeida, M. S. M. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.87.2020.tde-16052024-105416
Pathophysiology of Common Hearing Disorders: Mechanisms and Repair Options
Warnecke, A., & Staecker, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.24187-4
Genetics of Non-Syndromic Hearing Loss
Gaonakar, R. (2026) · Journal of chemical health risks
Luo, Y., Wu, K., Zhang, X., Wang, H., & Wang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.24934294
Self-citationAlleleAnalyzer: a tool for personalized and allele-specific sgRNA designPreprint
Keough, K. C., Lyalina, S., Olvera, M. P., Whalen, S., Conklin, B. R., & Pollard, K. S. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/342923
Age-Related Hearing Loss: Recent Findings and Emerging Questions
Sánchez‐Rodríguez, C. (2020) · Scholarly Journal of Otolaryngology · doi:10.32474/sjo.2020.04.000177
Jones, G. R. (2018) · ePublications at Regis University (Regis University)
胡, 宇., & 张, 伟. (2018) · Scientia Sinica Vitae · doi:10.1360/n052018-00033
DNA Recombinases as Genome Editing Tools
Bessen, J. L. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Physiopathological effects of noise: Recent approaches to the treatment of hearing loss
KÜSEN, H., Özdengül, F., Görmüş, Z. I. S., & Şen, A. (2022) · Journal of Surgery and Medicine · doi:10.28982/josam.906773
Furst, H. (2023) · Direito da Saúde Comparado · doi:10.56242/direitodasaudecomparado;2023;2;3;76-101
Gene therapy restores hearing in toddlers and teenagers born with congenital deafness – new research
Duan, M. (2025) · The Conversation · doi:10.64628/ab.jy5g7hpxs
Researcher claims CRISPR-edited twins are born. How will science respond?
Perrin, D., & Burgio, G. (2018) · The Conversation · doi:10.64628/aa.3jp4tejkv
Linhorst, A. (2018) · Publikationen an der Universität Bielefeld (Universität Bielefeld)
MANAGEMENT OF CONGENITAL HEARING LOSS: EARLY INTERVENTION STRATEGIES
Seabra, L. D. A., Linhares, I. D. S., SILVA, P. F. F., Vieira, S. N., Ribeiro, F. G., Filgueiras, F. B. G., da Silva, I. F., Lima, Y. H. P., Bolzan, A. C. S., Penha, T. A. S. A., et al. (2026) · International Seven Journal of Multidisciplinary · doi:10.56238/isevmjv5n1-005
Huang, J., 徐張哲, Wu, S., ZHANG, H., Liu, G. X., & Liu, B. Q. (2026) · Micromachines · doi:10.3390/mi17060678
CRISPR-Cas systems for targeted drug delivery
Srinivasan, B., Nangude, M. S., Sonawane, A., & Vinchurkar, K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40620-1.00011-x
Saddiq, A. M., Naaz, K., Nisar, S., & Hayat, S. M. H. (2023) · Eye-The International Social Science Review
Yu, C., Xu, H., Tong, L., Zhou, W., Zhang, M., Haiyan, Z., Yin, J., Wang, J., Han, J., Cao, Y., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.10.018
Metadata
- Authors
- Gao, X., Tao, Y., Lamas, V., Huang, M., Yeh, W.-H., Pan, B., Hu, Y.-J., Hu, J. H., Thompson, D. B., Shu, Y., Li, Y., Wang, H., Yang, S., Xu, Q., Polley, D. B., Liberman, M. C., Kong, W.-J., Holt, J. R., Chen, Z.-Y., & Liu, D. R.
- Affiliations
- Broad Institute (US)
- Massachusetts Eye and Ear Infirmary (US)
- Boston Children's Hospital (US)
- Howard Hughes Medical Institute (US)
- Tufts University (US)
- Corresponding author
- Chen, Zheng-Yi
- Liu, David R.
- ORCID
- Venue
- Nature
- Published
- 2017-12-20
- Volume
- 553
- Issue
- 7687
- Pages
- 217-221
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5784267
- OpenAlex
- W2778806019
- Cited by
- 536
- References
- 28
- Citations by year
- 2026: 25 · 2025: 43 · 2024: 58 · 2023: 62 · 2022: 64 · 2021: 60 · 2020: 101 · 2019: 67 · 2018: 54 · 2017: 1
- FWCI
- 37.88
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (2r01dc013521-11a1)
- National Institute on Deafness and Other Communication Disorders (R01-DC013521, R01DC009836, P30DC005209, R01DC006908, F32DC000138, R01DC000188)
- National Institute of General Medical Sciences (R35GM118062)
- National Institute of Biomedical Imaging and Bioengineering (R01EB022376)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD090255)
- Topics
- Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- autosomal dominant hearing loss, CRISPR/Cas9 genome editing, in vivo gene delivery, dominant negative mutation, auditory brainstem response, acoustic startle response
- MeSH terms
- Gene Editing, Acoustic Stimulation, Alleles, Animals, Animals, Newborn, Auditory Threshold, Base Sequence, Cell Survival, Cochlea, Disease Models, Animal, Female, Fibroblasts, Genes, Dominant, Hair Cells, Auditory, Humans, Liposomes, Male, Membrane Proteins, Reflex, Startle, Genetic Therapy, Evoked Potentials, Auditory, Brain Stem, Hearing Loss, Mice, CRISPR-Cas Systems, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.